Eunice Obeng Amoako
Dados Biográficos
| ID | 7770484 |
|---|---|
| NOME | Eunice Obeng Amoako |
| PRENOMES | Eunice Obeng |
| SOBRENOME | Amoako |
| ASSINATURA | AMOAKO E O |
| AFILIAÇÕES | Noguchi Memorial Institute for Medical Research |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2021 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023
Introduction Malaria case management in Ghana is a key intervention within the national malaria elimination agenda. Currently, artesunate-amodiaquine (AS-AQ), artemetherlumefantrine (AL), and artesunate-pyronaridine (AP) are the first-line medicines for treating uncomplicated malaria whilst dihydroartemisinin-piperaquine (DHAP) is the second-line medicine. Methods This was a one-arm prospective evaluation of the clinical, parasitological and haem…
Malaria parasitaemia and mRDT diagnostic performances among symptomatic individuals in selected health care facilities across Ghana
Malaria control interventions should be targeted at the general population, and history of antimalarial intake considered a key predictor of malaria slide negativity. Furthermore, HRP2-based mRDTs remain effective diagnostic tool in the management of suspected uncomplicated malaria in the country
Sem obras proeminentes nesta página.
Malaria parasitaemia and mRDT diagnostic performances among symptomatic individuals in selected health care facilities across Ghana
Malaria control interventions should be targeted at the general population, and history of antimalarial intake considered a key predictor of malaria slide negativity. Furthermore, HRP2-based mRDTs remain effective diagnostic tool in the management of suspected uncomplicated malaria in the country
Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023
Introduction Malaria case management in Ghana is a key intervention within the national malaria elimination agenda. Currently, artesunate-amodiaquine (AS-AQ), artemetherlumefantrine (AL), and artesunate-pyronaridine (AP) are the first-line medicines for treating uncomplicated malaria whilst dihydroartemisinin-piperaquine (DHAP) is the second-line medicine. Methods This was a one-arm prospective evaluation of the clinical, parasitological and haem…
Malaria (2 obras) · Malaria Research and Control (2 obras) · Biostatistics (1 obras) · Clinical trial (1 obras) · Combination therapy (1 obras) · Diagnostic test (1 obras) · Diverse Scientific Research Studies (1 obras) · Environmental health (1 obras) · Epidemiology (1 obras) · Global Maternal and Child Health (1 obras)